International Policy and Advocacy Advisory Board on Botanical Medicine

Established in 2023, the International Policy and Advocacy Advisory Board on Botanical Medicine brings together leading experts from Malaysia, the UK, Sweden, and the USA. The board plays a pivotal role in shaping progressive, evidence-based policies and responsible implementation of botanical medicines, including medical cannabis and kratom, across Southeast Asia.

The Advisory Board also supports a structured certification framework in medical cannabis education, designed to equip stakeholders with accurate, practical knowledge. To date, over 105 professionals—including healthcare providers, pharmacists, lawyers, and industry players—have been certified through our comprehensive 4-level program.

Key topics covered in the curriculum include:

• Medical cannabis laws and regulations
• Scientific and historical foundations
• Health and safety considerations
• Legal aspects of cultivation and distribution
• Distinctions between medical and recreational use

We invite healthcare professionals, policymakers, and regulatory agencies to collaborate with us in building a well-informed and ethically guided future for botanical medicine.